Suppr超能文献

TIGIT在HIV-1感染后上调,并标志着自然杀伤细胞中一个高度功能性的适应性成熟亚群。

TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.

作者信息

Vendrame Elena, Seiler Christof, Ranganath Thanmayi, Zhao Nancy Q, Vergara Rosemary, Alary Michel, Labbé Annie-Claude, Guédou Fernand, Poudrier Johanne, Holmes Susan, Roger Michel, Blish Catherine A

机构信息

Division of Infection Diseases and Geographic Medicine, Department of Medicine.

Department of Statistics.

出版信息

AIDS. 2020 May 1;34(6):801-813. doi: 10.1097/QAD.0000000000002488.

Abstract

OBJECTIVE

Our objective was to investigate the mechanisms that govern natural killer (NK)-cell responses to HIV, with a focus on specific receptor--ligand interactions involved in HIV recognition by NK cells.

DESIGN AND METHODS

We first performed a mass cytometry-based screen of NK-cell receptor expression patterns in healthy controls and HIV individuals. We then focused mechanistic studies on the expression and function of T cell immunoreceptor with Ig and ITIM domains (TIGIT).

RESULTS

The mass cytometry screen revealed that TIGIT is upregulated on NK cells of untreated HIV women, but not in antiretroviral-treated women. TIGIT is an inhibitory receptor that is thought to mark exhausted NK cells; however, blocking TIGIT did not improve anti-HIV NK-cell responses. In fact, the TIGIT ligands CD112 and CD155 were not upregulated on CD4 T cells in vitro or in vivo, providing an explanation for the lack of benefit from TIGIT blockade. TIGIT expression marked a unique subset of NK cells that express significantly higher levels of NK-cell-activating receptors (DNAM-1, NTB-A, 2B4, CD2) and exhibit a mature/adaptive phenotype (CD57, NKG2C, LILRB1, FcRγ, Syk). Furthermore, TIGIT NK cells had increased responses to mock-infected and HIV-infected autologous CD4 T cells, and to PMA/ionomycin, cytokine stimulation and the K562 cancer cell line.

CONCLUSION

TIGIT expression is increased on NK cells from untreated HIV individuals. Although TIGIT does not participate directly to the response to HIV-infected cells, it marks a population of mature/adaptive NK cells with increased functional responses.

摘要

目的

我们的目的是研究调控自然杀伤(NK)细胞对HIV反应的机制,重点关注NK细胞识别HIV过程中涉及的特定受体-配体相互作用。

设计与方法

我们首先对健康对照者和HIV感染者的NK细胞受体表达模式进行了基于质谱流式细胞术的筛选。然后,我们将机制研究聚焦于具有Ig和ITIM结构域的T细胞免疫受体(TIGIT)的表达和功能。

结果

质谱流式细胞术筛选显示,未接受抗逆转录病毒治疗的HIV感染女性的NK细胞上TIGIT表达上调,而接受抗逆转录病毒治疗的女性则没有。TIGIT是一种抑制性受体,被认为标志着耗竭的NK细胞;然而,阻断TIGIT并没有改善抗HIV的NK细胞反应。事实上,TIGIT配体CD112和CD155在体外或体内的CD4 T细胞上并未上调,这就解释了阻断TIGIT为何没有益处。TIGIT表达标志着NK细胞的一个独特亚群,该亚群表达显著更高水平的NK细胞激活受体(DNAM-1、NTB-A、2B4、CD2),并呈现成熟/适应性表型(CD57、NKG2C、LILRB1、FcRγ、Syk)。此外,TIGIT NK细胞对模拟感染和HIV感染的自体CD4 T细胞、对佛波酯/离子霉素、细胞因子刺激以及K562癌细胞系的反应增强。

结论

未接受治疗的HIV感染者的NK细胞上TIGIT表达增加。虽然TIGIT不直接参与对HIV感染细胞的反应,但它标志着一群功能反应增强的成熟/适应性NK细胞。

相似文献

3
Analysis of the Characteristics of TIGIT-Expressing CD3CD56NK Cells in Controlling Different Stages of HIV-1 Infection.
Front Immunol. 2021 Feb 26;12:602492. doi: 10.3389/fimmu.2021.602492. eCollection 2021.
4
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.
Cancer Res. 2016 Oct 1;76(19):5696-5706. doi: 10.1158/0008-5472.CAN-16-0839. Epub 2016 Aug 8.
6
CD155/TIGIT, a novel immune checkpoint in human cancers (Review).
Oncol Rep. 2021 Mar;45(3):835-845. doi: 10.3892/or.2021.7943. Epub 2021 Jan 19.
7
Contribution of inhibitory receptor TIGIT to NK cell education.
J Autoimmun. 2017 Jul;81:1-12. doi: 10.1016/j.jaut.2017.04.001. Epub 2017 Apr 21.
8
DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.
Int Immunol. 2021 Nov 25;33(12):687-692. doi: 10.1093/intimm/dxab085.
9
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
Clin Cancer Res. 2020 Oct 15;26(20):5520-5533. doi: 10.1158/1078-0432.CCR-20-0575. Epub 2020 Jun 26.
10
Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155.
Cancer Immunol Immunother. 2016 Mar;65(3):305-14. doi: 10.1007/s00262-016-1799-4. Epub 2016 Feb 3.

引用本文的文献

3
Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential.
mBio. 2025 Mar 12;16(3):e0322624. doi: 10.1128/mbio.03226-24. Epub 2025 Feb 7.
6
Immune checkpoint inhibitors in infectious disease.
Immunol Rev. 2024 Nov;328(1):350-371. doi: 10.1111/imr.13388. Epub 2024 Sep 9.
7
Immune restoration by TIGIT blockade is insufficient to control chronic SIV infection.
J Virol. 2024 Jun 13;98(6):e0027324. doi: 10.1128/jvi.00273-24. Epub 2024 May 22.
8
Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness.
Front Immunol. 2024 Feb 15;15:1334882. doi: 10.3389/fimmu.2024.1334882. eCollection 2024.
9
γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression.
Clin Transl Immunology. 2024 Jan 29;13(2):e1486. doi: 10.1002/cti2.1486. eCollection 2024.
10
Advances in HIV Research Using Mass Cytometry.
Curr HIV/AIDS Rep. 2023 Apr;20(2):76-85. doi: 10.1007/s11904-023-00649-x. Epub 2023 Jan 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验